← Open Payments lookup

LANCE GRIFFIN: Open Payments

NPI 1700212198 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,017 in 51 payments from 12 companies in 2025. Trend: 2023 $472 · 2024 $516 · 2025 $1,017

Food & beverage: $1,017
CompanyPaymentsAmount
ABBVIE INC.14$200
Takeda Pharmaceuticals U.S.A., Inc.10$199
Madrigal Pharmaceuticals5$147
Janssen Biotech, Inc.5$130
Aimmune Therapeutics, Inc.4$72
Lilly USA, LLC3$58
Regeneron Healthcare Solutions, Inc.3$57
Ipsen Biopharmaceuticals, Inc2$43
Celltrion USA Inc.2$32
ORPHALAN INC1$30

Products named: ENTYVIO, REZDIFFRA, TREMFYA, MAVYRET, VOWST, OMVOH, DUPIXENT, VIBERZI.

Industry payments across MT — which companies pay providers there.